40 likes | 57 Views
Epinephrine also called as adrenaline is a hormone and neurotransmitter produced by the adrenal glands.<br>
E N D
Epinephrine Market - Size, Share, Growth, Epinephrine Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Outlook, and Opportunity Analysis, 2018-2026 Epinephrine injection is used along with emergency medical treatment to treat life-threatening allergic reactions caused by insect bites, foods, medications, and other causes. The epinephrine auto- injectors are disposable, prefilled automatic injection devices, which are intended for self- administration of epinephrine solution in an emergency for on-the-spot treatment during early onset of symptoms of an anaphylactic reaction. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2401 Increasing support from government and insurance agencies for generic products to propel epinephrine market growth Launch of cost effective generic epinephrine products by the manufacturers is majorly attributed to the high price of EpiPen developed by Mylan NV. The price hike was not accepted by the public, as the drug price increased to more than 400% over a decade. According to data provided by Elsevier Clinical Solutions’ Gold Standard Drug Database, 2016, the cost of EpiPen was US$ 103.50 in 2009, where the price increased up to US$ 264.50 in 2013. The price of the product further increased by 75% costing around US$ 461 in 2015, whereas the price reached to US$ 608.61 in 2016. Increase in prevalence of chronic respiratory diseases to bolster the market growth Epinephrine is available in different doses and concentrations for delivery by different routes and for different indications, including respiratory disorders. According to the World Health Organization (WHO), 2018, Chronic Respiratory Diseases (CRDs) affect more than 1 billion people worldwide and asthma is a large contributor, affecting children, adults, and elderly population often throughout their entire lives. The WHO in 2017, stated that over 300 million patients suffered from asthma in 2013, and are expected to increase to over 400 million by 2025 globally.
North America dominates the global epinephrine market, owing to increasing number of patients suffering from respiratory disease such as asthma. For instance, according to the Asthma and Allergy Foundation of America, 2014, anaphylaxis is a severe life-threatening allergic reactions occurring at least 1 in every 50 people in the U.S., and its rate is as high as 1 in every 20 people. Report includes chapters which deeply display the following deliverable about industry : • Epinephrine Market Research Objective and Assumption • Epinephrine Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Epinephrine Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Epinephrine Market, By Regions • Epinephrine Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Epinephrine Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Epinephrine Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Epinephrine Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Major players operating in the global epinephrine market include Mylan N.V., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Impax Laboratories, Inc., Kaleo, Inc., Adamis Pharmaceuticals Corporation, Bausch Health Companies, and ALK- Abello A/S. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/2401
Detailed Segmentation: Global Epinephrine Market, By Product Type: • Auto-injector • Prefilled Syringes • Ampoules and Vials Global Epinephrine Market, By Application: • Anaphylaxis • Cardiac Arrest • Superficial Bleeding • Respiratory Disorders • Others Global Epinephrine Market, By Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies Global Epinephrine Market, By Geography: • North America • • • • Europe • Asia Pacific • Latin America • Middle East • Africa • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200
Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com